(2-甲氧基苄基)-硫脲 | 66892-30-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: (2-甲氧基苄基)-硫脲
• 英文名称: 1-(2-methoxybenzyl)thiourea
• 英文别名: N-(2-Methoxy-benzyl)-thioharnstoff；(2-methoxy-benzyl)-thiourea；(2-Methoxy-benzyl)-thioharnstoff；(2-methoxyphenyl)methylthiourea
• CAS: 66892-30-6
• 化学式: C₉H₁₂N₂OS
• mdl: MFCD03978472
• 分子量: 196.273
• InChiKey: GSRPPAKIJBKMEY-UHFFFAOYSA-N

物化性质

• 熔点：
  145 °C
• 沸点：
  331.3±44.0 °C(Predicted)
• 密度：
  1.198±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  79.4
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  邻甲氧基苄胺 在 氨 作用下， 生成 (2-甲氧基苄基)-硫脲
  参考文献：
  名称：

  Kjaer; Jensen, Acta Chemica Scandinavica (1947-1973), 1956, vol. 10, p. 141

  摘要：

  DOI：

文献信息

• Novel quinazoline derivatives and methods of treatment related to the use thereof
  申请人：Sekiguchi Yoshinori

  公开号：US20070010671A1

  公开（公告）日：2007-01-11

  The present invention relates to novel compounds of Formula (1): which act as MCH receptor antagonists. These compositions are useful in pharmaceutical compositions whose use includes prophylaxis or treatment of improving memory function, sleeping and arousal, anxiety, depression, mood disorders, seizure, obesity, diabetes, appetite and eating disorders, cardiovascular disease, hypertension, dyslipidemia, myocardial infarction, binge eating disorders including bulimia, anorexia, mental disorders including manic depression, schizophrenia, delirium, dementia, stress, cognitive disorders, attention deficit disorder, substance abuse disorders and dyskinesias including Parkinson's disease, epilepsy, and addiction.

  本发明涉及一种新的化合物，其化学式为(1)，并作为MCH受体拮抗剂。这些化合物在制药组合物中的使用包括预防或治疗改善记忆功能、睡眠和觉醒、焦虑、抑郁、情绪障碍、癫痫、肥胖症、糖尿病、食欲和进食障碍、心血管疾病、高血压、血脂异常、心肌梗塞、暴食障碍（包括贪食症、厌食症）、精神障碍（包括躁郁症、精神分裂症、谵妄、痴呆）、压力、认知障碍、注意力缺陷障碍、物质滥用障碍和运动障碍（包括帕金森病、癫痫和成瘾）。
• COMPOSITIONS AND METHODS FOR THE TREATMENT OF MALARIA
  申请人：Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences

  公开号：US20140296532A1

  公开（公告）日：2014-10-02

  The present invention provides aminohydantoin anti-malarial agents. In some embodiments, these agents have the property of functions of targeting malarial aspartic proteases while at the same time having low activity against human BACE. Methods of employing such agents are also provided.

  本发明提供了氨基咪唑啉类抗疟疾药物。在某些实施例中，这些药物具有靶向疟疾天冬氨酸蛋白酶的功能特性，同时对人类β-淀粉样蛋白前体酶的活性较低。本发明还提供了使用这些药物的方法。
• Trivedi; Trivedi, Journal of the Indian Chemical Society, 1958, vol. 35, p. 657,658
  作者：Trivedi、Trivedi

  DOI：——

  日期：——
• METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITIS
  申请人：President and Fellows of Harvard College

  公开号：US20210186906A1

  公开（公告）日：2021-06-24

  The invention features a method for inhibiting one or more voltage-gated ion channels in a cell by contacting the cell with (i) a first compound that activates a channel-forming receptor that is present on nociceptors and/or pruriceptors; and (ii) a second compound that inhibits one or more voltage-gated ion channels when applied to the internal face of the channels but does not substantially inhibit said channels when applied to the external face of the channels, wherein the second compound is capable of entering nociceptors or pruriceptors through the channel-forming receptor when the receptor is activated. The invention also features a quarternary amine derivative or other permanently or transiently charged derivative of a compound that inhibits one or more voltage-gated ion channels when applied to the internal face of the channels but does not substantially inhibit said channels when applied to the external face of the channels.
• US3991008A
  申请人：——

  公开号：US3991008A

  公开（公告）日：1976-11-09